---
tags:
  - course
ctime: 2024-04-17T23:06:23
mstime: 2024-04-17T23:06:23
level: graduate
subject: 
university: mit
completion: open
percentage: 0
prereq: Permission of instructor
coreq: None.
---

catalog [20.201](http://student.mit.edu/catalog/m20a.html#20.201)

<span style="display: block; padding: 15px; background-color: rgb(100, 100, 100, 0.2);"><font id="m_prereq2027_0" style="display: block; font-family: Arial, sans-serif; font-weight: bold; padding: 5px">Prerequisites</font><br><span id="prereq2027_0">Permission of instructor</span></span>
<span style="display: block; padding: 15px; background-color: rgb(100, 100, 100, 0.2);"><font id="m_coreq2027_0" style="display: block; font-family: Arial, sans-serif; font-weight: bold; padding: 5px">Corequisites</font><br><span id="coreq2027_0">None.</span></span>

<font style="">Description:</font>
<font style="color: grey; font-size: 0.8rem;">Team-based exploration of the scientific basis for developing new drugs. First portion of term covers fundamentals of target identification, drug discovery, pharmacokinetics, pharmacodynamics, regulatory policy, and intellectual property. Industry experts and academic entrepreneurs then present case studies of specific drugs, drug classes, and therapeutic targets. In a term-long project, student teams develop novel therapeutics to solve major unmet medical needs, with a trajectory to a "start-up" company. Culminates with team presentations to a panel of industry and scientific leaders.</font>



---

<< HELLO, WORLD >>
